The Independent Market Observer

Pandemic Indicators Show Signs of Improvement

Posted by Brad McMillan, CFA®, CFP®

Find me on:

This entry was posted on Dec 31, 2020 3:33:23 PM

and tagged In the News

Leave a comment

Looking at the data, Commonwealth CIO Brad McMillan says that, despite the headlines and real risks, we should be approaching the end of the pandemic.As expected, we have seen a pullback in many pandemic indicators over the Christmas holidays. We are also, again as expected, starting to see the data bounce back, indicating the drop was more due to slower reporting than an actual decline in cases. Looking forward, holiday travel may well give us another surge, so take the current better news with a grain of salt. While a peak is coming, we are not through this wave yet, despite encouraging signs from the Midwest.

That said, however, the signs of improvement are real. Even taking Christmas gatherings into account, the rate of case growth has slowed. Vaccinations have started. Although the headlines are about how slow the vaccination process has been, the pace will improve over the next couple of weeks. As the vaccinated population grows along with the population of people who have been exposed to the virus, that should help reduce infection rates. We are getting close to the worst of the pandemic, and may be there already. After the peak has been reached, more improvement should come steadily.

The economic news has continued to deteriorate, but here too we saw positive signs. Confidence and spending were down as lockdowns widened around the country. On the positive side, however, the federal government is in the final stages of passing a stimulus program that should support the economy over the next couple of months. Positive economic signs are appearing in the data already.

While the current headlines continue to be bad, there are signs of improvement and reasons to believe we are close to the bottom. That seems to be what markets are thinking, as a combination of slowly decreasing medical risks and economic resiliency has kept them close to all-time highs in the past weeks. Let’s take a look at the details.

Christmas Travel Cases May Be Showing Up in the Data

New cases per day. The most obvious metric for tracking the virus is daily new cases. We are now seeing a data distortion lull in the aftermath of the Christmas holiday, as we did with Thanksgiving, when a significant drop in new cases reversed. Now, as then, the drop is likely due to slower data reporting. As a consequence, case growth is very likely to bounce back as the holiday travel surge shows up over the next couple of weeks. While the lockdowns in many states are working, the third wave continues at a national level.

New daily infection rates were 234,775 on December 30, up slightly from 233,572 a week earlier. The seven-day average number of new cases per day was 185,704 per day, down from 216,683 a week ago, reflecting the drop in reported cases over Christmas. While case growth remains high, the good news is that the rate of increase may have slowed. If this trend continues, we could see the third wave peak in the next couple of weeks, once the post-holiday surge fades.  

Looking at the data, Commonwealth CIO Brad McMillan says that, despite the headlines and real risks, we should be approaching the end of the pandemic.

Source: https://www.worldometers.info/coronavirus/country/us/

Death rate. The death rate reporting is also showing the same trends. This is a lagging indicator, and runs from 6–8 weeks behind the case growth. As such, recent increases in the death rate reflect infection growth in mid to late November. On a seven-day moving average basis, daily deaths were at 2,364 as of December 30, down from 2,752 in the prior week. As the number of new cases has spiked since Thanksgiving, we can reasonably expect death rates to increase substantially over the coming weeks.

Looking at the data, Commonwealth CIO Brad McMillan says that, despite the headlines and real risks, we should be approaching the end of the pandemic.Source: https://www.worldometers.info/coronavirus/country/us/

Testing. Finally, we see that the testing news is also indicating we are not through the worst of the pandemic yet. Testing was down over the holiday and positive rates were back up. The good news is that, even though tests are down, the positive rate remains below the highs we’ve seen. This data, which is consistent with the slowing rate of case growth, could be a leading indicator of improvements.

The bottom line is that while the data is better, it does not indicate real improvement. Instead, the data is based on post-holiday reporting delays. That said, there are signs of moderation in the growth rate for new cases. These signs suggest that, absent the effects of holiday travel, things would look better. Once the effects of holiday travel work their way through the data, we should see improvement in the next couple of weeks. Given the deployment of vaccines, we should be approaching the end of the beginning. While the pandemic may well look worse over the next couple of weeks, the medium and longer-term pictures look brighter.

Looking at the data, Commonwealth CIO Brad McMillan says that, despite the headlines and real risks, we should be approaching the end of the pandemic.Source: The Johns Hopkins University https://coronavirus.jhu.edu/testing/individual-states/usa

Pandemic Economic Damage Continues

Jobs and consumers. Government-mandated shutdowns in response to the deterioration of the medical situation, along with changes in consumer behavior, have hit the economy hard in recent weeks. Job growth dropped from 638,000 in October to 245,000 in November. Layoffs have risen sharply for the past three weeks, although we did see a lower level of layoffs last week. Most affected are the low-wage workers, as shown in the chart below. With the employment market down, consumer confidence has softened further, leading to a sharp drop in retail spending as reported for the last month. Overall, the data suggests that the third wave has now hit a point where it will act as a significant drag on the economy until it reverses.

Testing. Finally, we see that the testing news is also indicating we are not through the worst of the pandemic yet. Testing was down over the holiday and positive rates were back up. The good news is that, even though tests are down, the positive rate remains below the highs we’ve seen. This data, which is consistent with the slowing rate of case growth, could be a leading indicator of improvements.  The bottom line is that while the data is better, it does not indicate real improvement. Instead, the data is based on post-holiday reporting delays. That said, there are signs of moderation in the growth rate for new cases. These signs suggest that, absent the effects of holiday travel, things would look better. Once the effects of holiday travel work their way through the data, we should see improvement in the next couple of weeks. Given the deployment of vaccines, we should be approaching the end of the beginning. While the pandemic may well look worse over the next couple of weeks, the medium and longer-term pictures look brighter. Pandemic Economic Damage Continues Jobs and consumers. Government-mandated shutdowns in response to the deterioration of the medical situation, along with changes in consumer behavior, have hit the economy hard in recent weeks. Job growth dropped from 638,000 in October to 245,000 in November. Layoffs have risen sharply for the past three weeks, although we did see a lower level of layoffs last week. Most affected are the low wage workers, as shown in the chart below. With the employment market down, consumer confidence has softened further, leading to a sharp drop in retail spending as reported for the last month. Overall, the data suggests that the third wave has now hit a point where it will act as a significant drag on the economy until it reverses.Source: https://tracktherecovery.org/

Business sector. Despite the slowing in the consumer economy, based on what we know so far, the business sector continues to do well. Business confidence and investment remain at pre-pandemic levels, although the risks here are rising as well.

The real question, going forward, is how durable this recovery is. Much of the data has remained solid despite the ongoing third wave, suggesting substantial resilience. The question is whether the accelerating damage will reverse the economic recovery before the vaccines can be widely deployed. But the efforts by Congress to provide more fiscal stimulus should help bridge that gap. If the stimulus bill passes, it should provide the kind of boost that supported economic growth in earlier waves. This should be especially true for the low-wage populations most at risk (as demonstrated in the chart above). The government support should get us through until vaccines start to make a difference. At that point, we should start to see consumer confidence and spending bounce back, as we saw after previous waves. While the risks are real, the federal stimulus will substantially mitigate the worst of them.

Financial Markets Hold Gains on Vaccine and Stimulus News

Markets continued to rally and hit all-time highs again. Reasons this week are again the start of vaccinations, as well as the expectation of more federal stimulus shortly. Both medical and economic risks now look to be close to peaking, so it is reasonable to conclude we are at the end of the beginning of the pandemic. Between the expected short-term cushion from the stimulus, and the expectation that vaccines will normalize the medical risks in 2021, markets are clearly looking for a much better 2021—and prices are responding.

Making Progress

The bad news this week is that we are not yet through the third wave and we can expect more case growth over the next couple of weeks. As the pandemic continues to get worse, we will also see the economic damage continue to mount. The good news is that vaccines are being distributed and there are signs that policy is starting to contain the virus. So, despite the short-term damage done by holiday travel, the medical risks may be within weeks of peaking. Similarly, while the economic news continues to be worrying, the federal government’s stimulus bill should provide enough cushion for the economy to keep growing until the medical risks are better contained.

The most likely case for the next couple of weeks appears to be some deterioration of the medical news, as holiday travel effects show up, but then slow improvement. Similarly, the economic data will remain soft in the short term, but should then show improvement as the stimulus package takes effect. Markets will likely keep bouncing around on new developments, so expect more volatility in the short term.

In the longer term, the good news is that vaccines are now rolling out increasingly quickly. In a couple of months, we should be approaching the end of the pandemic when the economy can normalize and start to really grow again. The stimulus package should help the economy bridge the gap to that point. Despite the headlines we are seeing today, and the real risks, we are making progress. We will get there—but it will just take a bit longer.


Subscribe via Email

New call-to-action
Crash-Test Investing

Hot Topics



New Call-to-action

Conversations

Archives

see all

Subscribe


Disclosure

The information on this website is intended for informational/educational purposes only and should not be construed as investment advice, a solicitation, or a recommendation to buy or sell any security or investment product. Please contact your financial professional for more information specific to your situation.

Certain sections of this commentary contain forward-looking statements that are based on our reasonable expectations, estimates, projections, and assumptions. Forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Past performance is not indicative of future results. Diversification does not assure a profit or protect against loss in declining markets.

The S&P 500 Index is a broad-based measurement of changes in stock market conditions based on the average performance of 500 widely held common stocks. All indices are unmanaged and investors cannot invest directly in an index.

The MSCI EAFE (Europe, Australia, Far East) Index is a free float‐adjusted market capitalization index that is designed to measure the equity market performance of developed markets, excluding the U.S. and Canada. The MSCI EAFE Index consists of 21 developed market country indices.

One basis point (bp) is equal to 1/100th of 1 percent, or 0.01 percent.

The VIX (CBOE Volatility Index) measures the market’s expectation of 30-day volatility across a wide range of S&P 500 options.

The forward price-to-earnings (P/E) ratio divides the current share price of the index by its estimated future earnings.

Third-party links are provided to you as a courtesy. We make no representation as to the completeness or accuracy of information provided on these websites. Information on such sites, including third-party links contained within, should not be construed as an endorsement or adoption by Commonwealth of any kind. You should consult with a financial advisor regarding your specific situation.

Member FINRASIPC

Please review our Terms of Use

Commonwealth Financial Network®